Diabetic foot ulcer (DFU) is the most typical and expensive sequela of diabetes mellitus, usually resulting in lower-extremity amputation with poor 5-year survival charges. Staphylococcus aureus is probably the most prevalent pathogen remoted from DFU, suggesting adaptation of S. aureus to the distinctive metabolic situations of diabetes.

Diabetes is a fancy metabolic dysfunction with will increase not solely in serum glucose ranges but in addition in ranges of different sugars, together with fructose, mannose, and glucose-6-phosphate (G6P). Nevertheless, the impact of metabolism of those sugars on the pathogenesis of S. aureus just isn’t totally understood.

On this research, we demonstrated that metabolism of G6P, fructose, and mannose induced larger expression of staphylococcal virulence components than did glucose metabolism, however solely G6P results had been impartial of glucose-mediated carbon catabolite repression, suggesting a physiologically related position in diabetes.

Our in vivo research additional demonstrated that G6P was extremely current in pores and skin adipose tissues of diabetic TALLYHO/JngJ mice, and subcutaneous an infection with S. aureus brought about considerably larger tissue necrosis and bacterial burden, in comparison with nondiabetic SWR/J mice.

Lastly, enhanced pathogenesis of S. aureus in diabetic TALLYHO/JngJ mice was considerably attenuated by deletion of the hexose phosphate transport (HPT) system. These outcomes recommend that G6P is a vital metabolic sign for S. aureus, enhancing the virulence in diabetes. A greater understanding of how G6P metabolism is linked to the virulence of S. aureus will result in the event of novel different therapeutics.

Sugars are important vitamins for S. aureus to outlive and proliferate inside the host. As a result of elevated serum glucose ranges are an indicator of diabetes, most research have targeted on the impact of glucose metabolism, and little or no is thought relating to the consequences of metabolism of different sugars on the pathogenesis of S. aureus in diabetes.

On this research, we demonstrated that G6P, which is very current in diabetes, can induce expression of staphylococcal virulence components that trigger extreme tissue necrosis and bacterial burden in pores and skin infections.

Our outcomes spotlight the significance of dietary management of blood sugar ranges, not solely glucose but in addition different extremely metabolizable sugars similar to G6P. A greater understanding of how activation of the HPT system is linked to the virulence of S. aureus will information growth of novel different therapeutics.

Elements Influencing Change in Serum Uric Acid after Administration of the Sodium-Glucose Cotransporter 2 Inhibitor Luseogliflozin in Sufferers With Kind 2 Diabetes Mellitus

Though sodium-glucose cotransporter 2 (SGLT2) inhibitors decrease serum uric acid, their long-term impact on uric acid metabolism just isn’t properly understood. We analyzed pooled information from research whereby sufferers with sort 2 diabetes mellitus (T2DM) acquired luseogliflozin-an SGLT2 inhibitor.

Upon stratifying sufferers by baseline glycated hemoglobin (HbA1c) or serum uric acid, decrease HbA1c or larger serum uric acid stage was related to a larger discount in serum uric acid after remedy.

At week 12 of remedy, a major enhance in urinary glucose/creatinine (Cr) ratio and urinary uric acid clearance/Cr clearance ratio (CUA /CCr ratio) and a major discount in serum uric acid had been noticed.

Comparability of the subgroups of sufferers with a discount or a rise in serum uric acid confirmed that the rise subgroup had a better estimated glomerular filtration price (eGFR) at baseline, and the eGFR was considerably lowered, related to a major discount within the CUA /CCr ratio.

A number of regression evaluation confirmed that the discount in serum uric acid within the luseogliflozin group was strongly related to baseline excessive serum uric acid, low HbA1c ranges, and a rise in eGFR. Luseogliflozin was proven to scale back serum uric acid by enhancing urinary uric acid excretion in affiliation with elevated urinary glucose.

Therapy with luseogliflozin resulted in elevated serum uric acid in some sufferers, which can be as a result of lowered glomerular filtration of uric acid by way of the tubuloglomerular suggestions. SGLT2 inhibitors lowered serum uric acid desirably in sufferers with T2DM with low HbA1c and excessive serum uric acid. This text is protected by copyright. All rights reserved.

Steroid profiling and genetic variants in Chinese language ladies with gestational diabetes mellitus

Earlier research have demonstrated that steroids had been related to gestational diabetes mellitus (GDM). Nevertheless, outcomes from completely different research remained inconsistent, and solely a restricted vary of steroids had been investigated in these research.

Subsequently, we aimed to investigate complete steroid profiling in Chinese language ladies with GDM throughout third-trimester being pregnant. In 97 Chinese language pregnant ladies, we measured steroid profile utilizing a LC-MS/MS technique, and calculated product-to-precursor ratios in metabolic pathways of steroids.

Then sixteen genetic variants of genes encoding steroidogenic enzymes had been genotyped by MassARRAY system. There have been vital variations (P < 0.05) and apparent modifications (fold change <0.67 or >1.5) in steroids (testosterone, estriol, pregnenolone and dehydroepiandrosterone) and product-to-precursor ratios (E2/T and T/AD) between GDM and management teams.

Hepatic insulin resistance (HIR) is taken into account to be an impartial predictor of metabolic problems and performs an necessary position in systemic irritation, which contributes to abnormalities in heart problems (CVD) threat components.

The purpose of this research was to research the connection between HIR and new markers of cardiovascular dangers, together with leptin/adiponectin ratio (L/A), lipoprotein(a) [Lp(a)], and tumor necrosis issue alpha (TNF-α), at comparable entire physique insulin sensitivity in non-diabetic people with or with out CVD and at excessive threat of growing sort 2 diabetes.

Diabetes (Type 1) Exosome RNA

P241-DB1 - Ask for price

Diabetes (Type 2) Exosome RNA

P241-DB2 - Ask for price

Custom Antibody titration by ELISA up to 2 rabbits and 1 bleed

ELISA-1 1
EUR 202

Canine C-Peptide ELISA Kit

RD-C-Peptide-c-48Tests 48 Tests
EUR 533

Canine C-Peptide ELISA Kit

RD-C-Peptide-c-96Tests 96 Tests
EUR 740

Canine C-Peptide ELISA Kit

DLR-C-Peptide-c-48T 48T
EUR 527
Description: A competitive inhibition quantitative ELISA assay kit for detection of Canine C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Canine C-Peptide ELISA Kit

DLR-C-Peptide-c-96T 96T
EUR 688
Description: A competitive inhibition quantitative ELISA assay kit for detection of Canine C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Canine C-Peptide ELISA Kit

RDR-C-Peptide-c-48Tests 48 Tests
EUR 557

Canine C-Peptide ELISA Kit

RDR-C-Peptide-c-96Tests 96 Tests
EUR 774

Rat Cytochrome-C (Cyt-c) protein WB +ve control

CYTC11-C 100 ul
EUR 286

Recombinant Borrelia burgdorferi Osp-C protein (OSP-C) control for Western blot

OSPC12-C 100 ul
EUR 286

FD Rapid GolgiStain™ kit - Solution C

PK401-C 250 ml
EUR 196

Human Apolipoprotein C-I protein control for WB

APOC11-C 100 ul
EUR 286

Human Apolipoprotein C-II protein control for WB

APOC22-C 100 ul
EUR 286

Human Apolipoprotein C-III protein control for WB

APOC32-C 100 ul
EUR 286

Purified Human C-Reactive Protein (CRP) control for WB

CRP12-C 100 ul
EUR 286

Purified Rat C-Reactive Protein (CRP) control for WB

CRP16-C 100 ul
EUR 286

Purified Dog C-Reactive Protein (CRP) control for WB

CRP18-C 100 ul
EUR 286

Human C-Peptide ELISA Kit

RD-C-Peptide-Hu-48Tests 48 Tests
EUR 387

Human C-Peptide ELISA Kit

RD-C-Peptide-Hu-96Tests 96 Tests
EUR 532

Mouse C-Peptide ELISA Kit

RD-C-Peptide-Mu-48Tests 48 Tests
EUR 446

Mouse C-Peptide ELISA Kit

RD-C-Peptide-Mu-96Tests 96 Tests
EUR 615

Rat C-Peptide ELISA Kit

RD-C-Peptide-Ra-48Tests 48 Tests
EUR 465

Rat C-Peptide ELISA Kit

RD-C-Peptide-Ra-96Tests 96 Tests
EUR 643

Human C-Peptide ELISA Kit

DLR-C-Peptide-Hu-48T 48T
EUR 398
Description: A competitive inhibition quantitative ELISA assay kit for detection of Human C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Human C-Peptide ELISA Kit

DLR-C-Peptide-Hu-96T 96T
EUR 511
Description: A competitive inhibition quantitative ELISA assay kit for detection of Human C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Mouse C-Peptide ELISA Kit

DLR-C-Peptide-Mu-48T 48T
EUR 450
Description: A competitive inhibition quantitative ELISA assay kit for detection of Mouse C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Mouse C-Peptide ELISA Kit

DLR-C-Peptide-Mu-96T 96T
EUR 582
Description: A competitive inhibition quantitative ELISA assay kit for detection of Mouse C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Rat C-Peptide ELISA Kit

DLR-C-Peptide-Ra-48T 48T
EUR 467
Description: A competitive inhibition quantitative ELISA assay kit for detection of Rat C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Rat C-Peptide ELISA Kit

DLR-C-Peptide-Ra-96T 96T
EUR 605
Description: A competitive inhibition quantitative ELISA assay kit for detection of Rat C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Human C-Peptide ELISA Kit

RDR-C-Peptide-Hu-48Tests 48 Tests
EUR 404

Human C-Peptide ELISA Kit

RDR-C-Peptide-Hu-96Tests 96 Tests
EUR 556

Mouse C-Peptide ELISA Kit

RDR-C-Peptide-Mu-48Tests 48 Tests
EUR 465

Mouse C-Peptide ELISA Kit

RDR-C-Peptide-Mu-96Tests 96 Tests
EUR 643

Rat C-Peptide ELISA Kit

RDR-C-Peptide-Ra-48Tests 48 Tests
EUR 486

Rat C-Peptide ELISA Kit

RDR-C-Peptide-Ra-96Tests 96 Tests
EUR 672

Human recombinant purified His-tag c-myc protein (~65 kda) control

MYC17-C 100 ul
EUR 286

Recombinant (E.coli) C. perfringens alpha toxin protein control for western blot

CPA11-C 100 ul
EUR 286

Recombinant (E.coli) C. perfringens beta toxin protein control for western blot

CPB12-C 100 ul
EUR 286

Recombinant (E.coli) C. perfringens epsilon toxin protein control for western blot

CPE13-C 100 ul
EUR 286

Recombinant (NS0) purified Mouse C-Reactive Protein (CRP) cotnrol for Western

CRP21-C 100 ul
EUR 286

Recombinant (NS0) purified Mouse C-Reactive Protein (CRP) cotnrol for Western

CRP24-C 100 ul
EUR 286

Recombinant purified Circumsporozoite (CSP, P.falciparum) C-terminal (207-397 aa) His-tag protein control for Western Blot

CSPF11-C 100 ul
EUR 286

Multi Fusion-Tagged recombinant Protein 52-Kda containing 16-tags (T-7, HSV, C-myc, VSV-G, Glu-Glu, V5, e-tag, Flag, S-tag, HA, KT3, E2, Au1, Au5, 6xHis-tags) for ELISA/Western

MFPM52-C 100 ul
EUR 286

c-Myc Oncoprotein; Clone 9E10.3 (Concentrate)

RA0226-C.1 0.1 ml
EUR 125

c-Myc Oncoprotein; Clone 9E10.3 (Concentrate)

RA0226-C.5 0.5 ml
EUR 300

c-Myc Oncoprotein; Clone MYC909 (Concentrate)

RA0227-C.1 0.1 ml
EUR 125

c-Myc Oncoprotein; Clone MYC909 (Concentrate)

RA0227-C.5 0.5 ml
EUR 300

Recombinant purified his-tag-Protein (~130 kda) control for ELISA

HISP130-C 10 ug
EUR 286

Cytochrome c (Mitochondrial Marker); Clone 7H8.2C12 (Concentrate)

RA0359-C.1 0.1 ml
EUR 125

Cytochrome c (Mitochondrial Marker); Clone 7H8.2C12 (Concentrate)

RA0359-C.5 0.5 ml
EUR 300

Cytochrome c (Mitochondrial Marker); Clone CTC05 (Concentrate)

RA0360-C.1 0.1 ml
EUR 125

Cytochrome c (Mitochondrial Marker); Clone CTC05 (Concentrate)

RA0360-C.5 0.5 ml
EUR 300

Monkey IgM (Rhesus, non-immune control) for ELISA Kit, 1 ml (target range ~20-30 ug/ml)

7060-C 1 ml
EUR 286

Tenascin C (Stromal Marker For Epithelial Malignancy); Clone T2H5 (Concentrate)

RA0135-C.1 0.1 ml
EUR 125

Tenascin C (Stromal Marker For Epithelial Malignancy); Clone T2H5 (Concentrate)

RA0135-C.5 0.5 ml
EUR 247

Cytokeratin 8/18 (Epithelial Marker); Clone C-43 & DC10 (Concentrate)

RA0388-C.1 0.1 ml
EUR 125

Cytokeratin 8/18 (Epithelial Marker); Clone C-43 & DC10 (Concentrate)

RA0388-C.5 0.5 ml
EUR 300

Multi Fusion-Tagged Protein Marker containing 5 tags (His, T7, Myc, HA, VSV-G tags) Protein (Pure ~20 Kda) for ELISA/Western

MFPM20-C 100 ul
EUR 286

HER-2 / c-erbB-2 / neu / CD340; Clone HRB2/451 (Concentrate)

RA0108-C.1 0.1 ml
EUR 125

HER-2 / c-erbB-2 / neu / CD340; Clone HRB2/451 (Concentrate)

RA0108-C.5 0.5 ml
EUR 300

CD117/c-Kit (Marker for Gastrointestinal Stromal Tumors); Clone C117/370 (Concentrate)

RA0168-C.1 0.1 ml
EUR 125

CD117/c-Kit (Marker for Gastrointestinal Stromal Tumors); Clone C117/370 (Concentrate)

RA0168-C.5 0.5 ml
EUR 300

Human PSA ELISA Combo Kit (Free + Total)

PRB-5049-C 96 assays
EUR 833

S-Adenosylmethionine (SAM) and S-Adenosylhomocysteine (SAH) ELISA Combo Kit

STA-671-C 96 assays
EUR 867
Description: S-adenosylmethionine (SAM) is a substrate for methyl transfers to various biomolecules that yields S-adenosylhomocysteine (SAH). SAH is then hydrolyzed to homocysteine and adenosine, which is converted to methionine, and ultimately back to SAM. SAH can act as a methylation inhibitor, therefore the SAM/SAH ratio, or methylation potential, is important for maintaining proper methylation in the cell. Our S-Adenosylmethionine (SAM) and S-Adenosylhomocysteine (SAH) ELISA Combo Kit is designed for detection and quantitation of both SAM and SAH in plasma, serum, lysates, or biological fluid samples. This assay is a competitive ELISA where samples and an anti-SAM or anti-SAH antibody are added to a plate coated with a SAM or SAH conjugate. The sample and conjugate compete for antibody binding, which generates a reverse curve. Samples with high SAM and SAH levels will bind the majority of the antibody, which gets washed away and results in a low OD, while samples with low SAM and SAH levels will leave more antibody available to bind to the conjugate, producing a high signal.

OxiSelect Aldehyde-Induced DNA Damage ELISA Combo Kit (Ethenoadenosine / Ethenocytidine Quantitation)

STA-820-C 96 assays
EUR 798
Description: The OxiSelect Aldehyde-Induced DNA Damage ELISA Combo Kit (Ethenoadenosine / Ethenocytidine Quantitation) is a competitive ELISA kit allowing the quantitation of ethenoadenosine or ethenocytidine adducts in DNA isolated from cells or tissues. Samples and standards are added to a provided microplate preabsorbed with etheno-damaged DNA. A primary antibody is added and binds competitively to ethenoadenosine in the unknown sample or to the etheno adduct in the DNA coated on the plate. After washing a secondary antibody is added. A low signal means most of the primary antibody was bound to the unknown, indicating a high level of etheno adducts in the sample. Each combo kit can perform up to 96 assays combined for ethenoadenosine and ethenocytidine. The two targets are assayed in separate wells, but any well on the provided plate may be used for either target in any ratio (e.g. 64 wells for ethenoadenosine and 32 wells for ethenocytidine, or 48 wells for each).

OxiSelect UV-Induced DNA Damage ELISA Combo Kit (CPD / 6-4PP Quantitation)

STA-322-C 96 assays
EUR 827
Description: Our OxiSelect UV-Induced DNA Damage ELISA Combo Kit measures the formation of both CPD and 6-4PP structures in DNA isolated from cells or tissues. Standards or unknown DNA samples are first heat denatured before adsorbed onto a 96-well DNA binding plate.  The sample or standard are then probed with an anti-6-4PP or CPD antibody, followed by an HRP conjugated secondary antibody. CPD and 6-4PP structures are assayed on the same plate but in separate wells.

SCREW CAPS WITH "O" RINGS. CLEAR

SCO-C 500/pk
EUR 370
Description: Micro Tubes; Screw-Cap Microtubes - Axygen

Nuc-CFP (Puro), LocLight lentiviral particles

LVP360-C 1x107 IFU/ml x 200ul
EUR 507
Description: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene. CFP fluorescent signal only showed in nucleus area targeted by an improved NLS (Nuclear localization sequence) signal.

CFP-LC3 fusion lentiviral particles

LVP399-C 1x107 IFU/ml x 200ul
EUR 451
Description: Pre-made lentiviral particles expressing a CFP-LC3 fusion target (NM_022818.4), provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CFP-Histone 2B fusion lentiviral particles

LVP444-C 1x107 IFU/ml x 200ul
EUR 451
Description: Pre-made lentiviral particles expressing (CFP-human Histone 2B) fusion contruct under suCMV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CFP-Annexin5 fusion Lentiviral particles

LVP445-C 1x107 IFU/ml x 200ul
EUR 451
Description: Pre-made lentiviral particles expressing (CFP-human Annexin 5) fusion contruct under suCMV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CFP-Actin fusion Lentiviral particles

LVP446-C 1x107 IFU/ml x 200ul
EUR 451
Description: Pre-made lentiviral particles expressing (CFP-human Actin) fusion contruct under suCMV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CFP-TAT fusion Lentiviral particles

LVP447-C 1x107 IFU/ml x 200ul
EUR 451
Description: Pre-made lentiviral particles expressing (CFP-HIV-1 Tat) fusion contruct under suCMV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CFP-hP53 fusion Lentiviral particles

LVP448-C 1x107 IFU/ml x 200ul
EUR 451
Description: Pre-made lentiviral particles expressing (CFP-human P53) fusion contruct under suCMV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CFP-Zyxin fusion Lentiviral particles

LVP449-C 1x107 IFU/ml x 200ul
EUR 451
Description: Pre-made lentiviral particles expressing (CFP-human Zyxin) fusion contruct under suCMV promoter, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

Cyto-CFP (Puro), LocLight lentiviral particles

LVP450-C 1x107 IFU/ml x 200ul
EUR 507
Description: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene. CFP fluorescent signal only showed in Cytoplasm area targeted by an engineered nuclear export signal.

Golgoi-CFP (Bsd), LocLight lentiviral particles

LVP451-C 1x107 IFU/ml x 200ul
EUR 507
Description: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene. CFP fluorescent signal targeted in Golgoi by the golgi retention signal from 1, 4-galactosyltransferase (GT).

Mito-CFP (Bsd), LocLight lentiviral particles

LVP452-C 1x107 IFU/ml x 200ul
EUR 507
Description: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene. CFP fluorescent signal targeted in Mitochondria. It contains the Blasticidin selection marker.

Nuc-membrane-CFP (Puro), LocLight lentiviral particles

LVP453-C 1x107 IFU/ml x 200ul
EUR 507
Description: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene. CFP fluorescent signal targeted in Nuclear Membrane by the inner nuclear membrane localization signal from lamin B membrane receptor.

Peroxisome-CFP (Puro), LocLight lentiviral particles

LVP454-C 1x107 IFU/ml x 200ul
EUR 507
Description: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene. CFP fluorescent signal targeted in Peroxisome by the Peroxisomal C-terminal SKL targeting sequence.

Plasma-mem-CFP (Puro), LocLight lentiviral particles

LVP455-C 1x107 IFU/ml x 200ul
EUR 507
Description: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene. CFP fluorescent signal targeted in Plasma membrane by ADP-ribosylation factor 6, a plasma membrane protein.

Microtubule-CFP (Puro), LocLight lentiviral particles

LVP456-C 1x107 IFU/ml x 200ul
EUR 507
Description: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene. CFP fluorescent signal targeted in Microtubule by microtubule-associated protein 4 (MAP4).

Lysosomes-CFP (Bsd), LocLight lentiviral particles

LVP457-C 1x107 IFU/ml x 200ul
EUR 507
Description: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene. CFP fluorescent signal targeted in Lysosomes by lysosomal associated membrane protein 1 (LAMP1).

Endosomes-CFP (Puro), LocLight lentiviral particles

LVP458-C 1x107 IFU/ml x 200ul
EUR 507
Description: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene. CFP fluorescent signal targeted in Endosomes by RAB5A that localized to early endosomes for endocytosis and endocytic-sorting pathways.

CFP-CLCN2 fusion lentiviral particles

LVP550-C 1x107 IFU/ml x 200ul
EUR 451
Description: Pre-made lentiviral particles expressing afusion target of (CFP-human KCNN4), provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CFP-KCNN4 fusion lentiviral particles

LVP551-C 1x107 IFU/ml x 200ul
EUR 451
Description: Pre-made lentiviral particles expressing afusion target of (CFP-human CLCN2), provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CFP-TRPV1 fusion lentiviral particles

LVP552-C 1x107 IFU/ml x 200ul
EUR 451
Description: Pre-made lentiviral particles expressing afusion target of (CFP-human TRPV1), provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CFP-TRPC3 fusion lentiviral particles

LVP554-C 1x107 IFU/ml x 200ul
EUR 451
Description: Pre-made lentiviral particles expressing afusion target of (CFP-human TRPC3), provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

CFP-CSF1 fusion lentiviral particles

LVP556-C 1x107 IFU/ml x 200ul
EUR 451
Description: Pre-made lentiviral particles expressing a fusion target of (CFP-human CSF1) containing a Puromycin marker, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

ER-GFP (Puro), LocLight lentiviral particles

LVP606-C 1x107 IFU/ml x 200ul
EUR 507
Description: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene. CFP fluorescent signal targeted at Endoplasmic Reticulum (ER).

Mito-GFP (Puro), LocLight lentiviral particles

LVP893-C 1x107 IFU/ml x 200ul
EUR 507
Description: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene. CFP fluorescent signal targeted in Mitochondria. It contains the Puromycin selection marker.

Mito-GFP (Neo), LocLight lentiviral particles

LVP894-C 1x107 IFU/ml x 200ul
EUR 507
Description: Pre-made lentiviral particles for sub-cellular fluorescent labeling, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene. CFP fluorescent signal targeted in Mitochondria. It contains the Neomycin selection marker.

80-Well Rack, Natural Cover Only

R567-C 1 UNIT
EUR 51.57

96-Well Rack, Reversible, Natural Cover Only

R577-C 1 UNIT
EUR 51.74

uv lamp 1x15w, 254nm

VL115-C ea
EUR 656

uv lamp 2x15w, 254nm

VL215-C ea
EUR 792

uv lamp 1x6w, 254nm

VL6-C ea
EUR 521

cross-linker 254nm

VLBLX-C ea
EUR 1873

uv tube 15 w, 254 nm

VLT15-C ea
EUR 56

uv tube 4 w, 254 nm

VLT4-C ea
EUR 56

uv tube 6 w, 254 nm

VLT6-C ea
EUR 56

uv tube 8 w, 254 nm

VLT8-C ea
EUR 56

NATtrol Clostridium difficile Verification Panel (6 X 1 mL)

NATCDIVP-C 6 X 1 mL
EUR 532.56
Description: Please contact Gentaur in order to receive the datasheet of the product.

NATtrol CARBA-R Verification Panel (10 x 0.06 mL)

NATCRVP-C 10 x 0.06 mL
EUR 270.48
Description: Please contact Gentaur in order to receive the datasheet of the product.

NATtrol EV Panel (20 X 0.2 mL)

NATEVP-C 20 X 0.2 mL
EUR 601.2
Description: Please contact Gentaur in order to receive the datasheet of the product.

NATtrol Influenza/RSV Verification Panel (21 x 0.5mL)

NATFRVP-C 21 x 0.5mL
EUR 765.52
Description: Please contact Gentaur in order to receive the datasheet of the product.

NATtrol MRSA Verification Panel (6 X 0.5mL)

NATMRSANP-C 6 X 0.5mL
EUR 398.4
Description: Please contact Gentaur in order to receive the datasheet of the product.

NATtrol MRSA Panel (4 X 0.5 mL)

NATMRSAP-C 4 X 0.5 mL
EUR 284
Description: Please contact Gentaur in order to receive the datasheet of the product.

NATtrol MTB Verification Panel (5 x 0.6mL, 6 x 1.6mL)

NATMTBP-C 5 x 0.6mL, 6 x 1.6mL
EUR 555.44
Description: Please contact Gentaur in order to receive the datasheet of the product.

NATtrol Strep A Verification Panel (24 x 0.1mL)

NATSAVP1-C 24 x 0.1mL
EUR 632.4
Description: Please contact Gentaur in order to receive the datasheet of the product.

NATtrol T.vaginalis Verification Panel (17 x 0.7 mL)

NATTVGP-C 17 x 0.7 mL
EUR 645.92
Description: Please contact Gentaur in order to receive the datasheet of the product.

DIRECTPCR LYSIS REAGENT (CELL)

301-C 50 ml
EUR 141
Description: For use with cultured cells

DIRECTPCR LYSIS REAGENT (CELL)

302-C 100 ml
EUR 207
Description: For use with cultured cells

Human Cell-18 protein lysate for WB positive control for ERA12-A protein (PR) IgG #2

ERA12-C 100 ul
EUR 286

Purified Human Neutrophil Elastase protein control for WB

ESTE11-C 100 ul
EUR 286

Recombinant Zaire-Ebola virus nucleoprotein (Mayinga EBOV NP) protein control for Western

EVNP11-C 100 ul
EUR 286

Recombinant (E. coli) Zaire-Ebola virus nucleoprotein (Mayinga EBOV NP) protein control for Western

EVNP13-C 100 ul
EUR 286

Human Heart Fatty acid binding protein (FABP) purified, WB +Ve control

FABP11-C 100 ul
EUR 286

Mouse Heart Fatty acid binding protein (FABP) purified WB +Ve control

FABP12-C 100 ul
EUR 286

Rat Heart Fatty acid binding protein (FABP) purified WB +Ve control

FABP13-C 100 ul
EUR 286

Monkey Heart Fatty acid binding protein (FABP) purified WB +Ve control

FABP14-C 100 ul
EUR 286

Rabbit Heart Fatty acid binding protein (FABP) purified WB +Ve control

FABP15-C 100 ul
EUR 286

Dog Heart Fatty acid binding protein (FABP) purified WB +Ve control

FABP16-C 100 ul
EUR 286

Pig Heart Fatty acid binding protein (FABP) purified WB +Ve control

FABP17-C 100 ul
EUR 286

Mouse Liver Fatty acid binding protein (FABP) purified WB +Ve control

FABP21-C 100 ul
EUR 286

Rat Liver Fatty acid binding protein (FABP) purified WB +Ve control

FABP22-C 100 ul
EUR 286

Rat FAS Ligand Recombinant protein for Western

FASL11-C 100 ul
EUR 286

Human soluble FAS Ligand (FASL/CD95L) Recombinant protein for Western

FASL12-C 100 ul
EUR 286

Human Ferritin (H-chain) recombinant protein WB +ve control

FERH13-C 100 ul
EUR 286

Human Ferritin (L-chain) recombinant protein WB +ve control

FERL14-C 100 ul
EUR 286

Human Spleen Ferritin protein Western blot +ve control

FERT11-C 100 ul
EUR 286

Human Liver Ferritin protein Western blot +ve control

FERT12-C 100 ul
EUR 286

Horse Spleen Ferritin protein Western blot +ve control

FERT13-C 100 ul
EUR 286

Human Heart Ferritin WB +ve protein control

FERT16-C 100 ul
EUR 286

Human Liver Ferritin WB +ve protein control

FERT17-C 100 ul
EUR 286

Purified rat liver Ferritin protein WB +ve protein control

FERT25-C 100 ul
EUR 286

Purified mouse liver Ferritin protein WB +ve protein control

FERT31-C 100 ul
EUR 286

Purified bovine Fetuin A (Alpha-2 HS-Glycoprotein, AHSG, A2HS) protein control for WB

FETA11-C 100 ul
EUR 286

Recombinant purified Human Fetuin A (Alpha-2 HS-Glycoprotein, AHSG, A2HS) protein control for WB

FETA13-C 100 ul
EUR 286

Recombinant purified Mouse Fetuin A (Alpha-2 HS-Glycoprotein, AHSG, A2HS) protein control for WB

FETA14-C 100 ul
EUR 286

Purified human serum Fetuin A (Alpha-2 HS-Glycoprotein, AHSG, A2HS) protein control for WB

FETA15-C 100 ul
EUR 286

Purified bovine Fetuin A (Alpha-2 HS-Glycoprotein, AHSG, A2HS) protein control for WB

FETB11-C 100 ul
EUR 286

Purified human Fetuin A (Alpha-2 HS-Glycoprotein, AHSG, A2HS) protein control for WB

FETB12-C 100 ul
EUR 286

Rec. (E.coli) Human Fibrinogen-like protein 2 (FGL2) protein control for Western blot

FGL22-C 100 ul
EUR 286

Rec. (CHO) Mouse Fibrinogen-like protein 2 (FGL2) protein control for Western blot

FGL23-C 100 ul
EUR 286

Purified B. pertussis Filamentous hemeagglutinin (FHA) protein control for Western

FHA11-C 100 ul
EUR 286

Purified Bordetella pertussis serotype 2 fimbrial subunit (Fim 2) control for western blot

FIM25-C 100 ul
EUR 286

Purified Bordetella pertussis fimbrial serotype 3 fimbrial subunit (Fim3) control for western blot

FIM35-C 100 ul
EUR 286

Recombinant purified FLAG tag-Protein (~9 kda) control WB +ve control

FLAG12-C 100 ul
EUR 286

Recombinant purified FLAG tag-Protein (~50 kda) control WB +ve control

FLAG13-C 100 ul
EUR 286

Purified Flagellin (salmonella) protein control for WB

FLGN17-C 100 ul
EUR 286

Recombinant Foot and mouth disease virus serotype A viral protein 1 (FMDA1-VP1) control for western blot

FMDA11-C 100 ul
EUR 286

Recombinant FMD (FMDA1-VP1) serotype A1 protein control for western blot

FMDA16-C 100 ul
EUR 286

Recombinant Foot and mouth disease virus serotype O, 2B (FMDO-2B) protein control for western blot

FMDO2B11-C 100 ul
EUR 286

Recombinant Foot and mouth disease virus serotype O, 2C (FMDO-2C) protein control for western blot

FMDO2C11-C 100 ul
EUR 286

Recombinant Foot and mouth disease virus serotype O, 3AB (FMDO-3AB) protein control for western blot

FMDO3AB11-C 100 ul
EUR 286

Recombinant FMD serotype O, 3C protein control for western blot

FMDO3C11-C 100 ul
EUR 286

Foot and mouth disease virus serotype O, 3D (FMDO-3D) protein control for western blot

FMDO3D11-C 100 ul
EUR 347

Recombinant FMD serotype O, viral protein 1 (FMDO-VP1) control for western blot

FMDOVP11-C 100 ul
EUR 286

Recombinant Foot and mouth disease virus serotype O, viral protein 1 (FMDO-VP1) Tetanus Toxoid light chain (TTLC) fusion control for western blot

FMDOVPF11-C 100 ul
EUR 286

Recombinant FMD serotype SAT-1, partial viral protein (FMDS-VP1) protein control for western blot

FMDS11-C 100 ul
EUR 286

Recombinant FMD serotype SAT-2, viral protein 1 (FMDS2-VP1) control for western blot

FMDS21-C 100 ul
EUR 286

Z-Leu-Gly-OH

C-2140.0025 25.0g
EUR 611
Description: Sum Formula: C16H22N2O5; CAS# [2706-38-9]

Z-Leu-Leu-OH

C-2150.0005 5.0g
EUR 176
Description: Sum Formula: C20H30N2O5; CAS# [7801-71-0]

Z-Leu-Leu-OH

C-2150.0025 25.0g
EUR 611
Description: Sum Formula: C20H30N2O5; CAS# [7801-71-0]

We searched Medline, Embase, the Cochrane Library, and gray literature sources as much as August 2021 for randomized managed trials (RCTs) that in contrast sotagliflozin with placebo or different antidiabetic brokers in sufferers with sort 2 diabetes. Our main final result was change in HbA1c from baseline.

LEAVE A REPLY

Please enter your comment!
Please enter your name here